Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy

Information

  • Research Project
  • 9339656
  • ApplicationId
    9339656
  • Core Project Number
    R41DE026083
  • Full Project Number
    5R41DE026083-02
  • Serial Number
    026083
  • FOA Number
    PA-15-270
  • Sub Project Id
  • Project Start Date
    9/1/2016 - 7 years ago
  • Project End Date
    8/31/2017 - 6 years ago
  • Program Officer Name
    LOPEZ, ORLANDO
  • Budget Start Date
    5/1/2017 - 7 years ago
  • Budget End Date
    8/31/2017 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    02
  • Suffix
  • Award Notice Date
    4/18/2017 - 7 years ago

Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy

Project Summary/Abstract Eradication of bacteria that are located in periodontal pockets is a daunting challenge to dentists and oral care professionals. Doxycycline or minocycline with scaling and root planing (S&RP) have been the mainstays, but the field urgently needs further advances in perio bacteria eradication. A high precision, photochemical implement that could be used simultaneously with S&RP would reduce or eliminate these problems. The development of a device for the precise delivery of reactive singlet oxygen would be a major breakthrough for periodontal photodynamic therapy (PDT). The device tip is superhydrophobic and capable of delivering singlet oxygen (a cytotoxic excited state of molecular oxygen) in a controllable fashion. The device offers precise delivery of singlet oxygen to hypoxic bacterial pockets, creating a highly-localized killing zone. We have developed an innovative superhydrophobic-tipped device, which can be inserted at the infection site. The tip discharges singlet oxygen at the infection site and nowhere else in the mouth. The objective of this proposal is to design device tips and validate their use in vitro with hypoxic mixed cultures and saliva biofilms.

IC Name
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
  • Activity
    R41
  • Administering IC
    DE
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    76210
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    121
  • Ed Inst. Type
  • Funding ICs
    NIDCR:76210\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SINGLETO2 THERAPEUTICS, LLC
  • Organization Department
  • Organization DUNS
    079935653
  • Organization City
    NEW PROVIDENCE
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    079742426
  • Organization District
    UNITED STATES